BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 29424731)

  • 1. Efficacy of cardiac shock wave therapy in patients with stable angina: The design of randomized, triple blind, sham-procedure controlled study.
    Shkolnik E; Burneikaite G; Celutkiene J; Scherbak M; Zuoziene G; Petrauskiene B; Trush E; Laucevicius A; Vasyuk Y
    Anatol J Cardiol; 2018 Feb; 19(2):100-109. PubMed ID: 29424731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of cardiac shock wave therapy on myocardial function and perfusion in the randomized, triple-blind, sham-procedure controlled study.
    Čelutkienė J; Burneikaitė G; Shkolnik E; Jakutis G; Vajauskas D; Čerlinskaitė K; Zuozienė G; Petrauskienė B; Puronaitė R; Komiagienė R; Butkuvienė I; Steponėnienė R; Misiūra J; Laucevičius A
    Cardiovasc Ultrasound; 2019 Jul; 17(1):13. PubMed ID: 31272465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, triple-blind trial of cardiac shock-wave therapy on exercise tolerance and symptoms in patients with stable angina pectoris.
    Shkolnik E; Burneikaite G; Jakutis G; Scherbak M; Zuoziene G; Petrauskiene B; Trush E; Vasyuk Y; Laucevicius A; Celutkiene J
    Coron Artery Dis; 2018 Nov; 29(7):579-586. PubMed ID: 29912782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shock-Wave Therapy Improves Myocardial Blood Flow Reserve in Patients with Refractory Angina: Evaluation by Real-Time Myocardial Perfusion Echocardiography.
    Ceccon CL; Duque AS; Gowdak LH; Mathias W; Chiang HP; Sbano JCN; Lima MF; Machado Cesar LA; Cruz CBBV; Dourado PMM; Meneghetti C; Tsutsui JM
    J Am Soc Echocardiogr; 2019 Sep; 32(9):1075-1085. PubMed ID: 31235421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter trial of extracorporeal cardiac shock wave therapy for refractory angina pectoris: report of the highly advanced medical treatment in Japan.
    Kikuchi Y; Ito K; Shindo T; Hao K; Shiroto T; Matsumoto Y; Takahashi J; Matsubara T; Yamada A; Ozaki Y; Hiroe M; Misumi K; Ota H; Takanami K; Hiraide T; Takase K; Tanji F; Tomata Y; Tsuji I; Shimokawa H
    Heart Vessels; 2019 Jan; 34(1):104-113. PubMed ID: 29942978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac shock wave therapy improves myocardial perfusion and preserves left ventricular mechanics in patients with refractory angina: A study with speckle tracking echocardiography.
    Duque AS; Ceccon CL; Mathias W; Majesky JD; Gowdak LH; Sbano JCN; Cesar LAM; Abduch MC; Lima MSM; Dourado PMM; Cruz CBBV; Tsutsui JM
    Echocardiography; 2018 Oct; 35(10):1564-1570. PubMed ID: 29962073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase II, sham-controlled, double-blinded study testing the safety and efficacy of the coronary sinus reducer in patients with refractory angina: study protocol for a randomized controlled trial.
    Jolicœur EM; Banai S; Henry TD; Schwartz M; Doucet S; White CJ; Edelman E; Verheye S
    Trials; 2013 Feb; 14():46. PubMed ID: 23413981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized and double-blind controlled clinical trial of extracorporeal cardiac shock wave therapy for coronary heart disease.
    Yang P; Guo T; Wang W; Peng YZ; Wang Y; Zhou P; Luo ZL; Cai HY; Zhao L; Yang HW
    Heart Vessels; 2013 May; 28(3):284-91. PubMed ID: 22457097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shenzhu Guanxin Recipe Granules () for Improving Exercise Tolerance in Patients with Stable Angina (SERIES Trial): A Protocol of Multicenter, Randomized, Double-Blind, Placebo Parallel Controlled Clinical Trial.
    Mao S; Xu DP; Dang XJ; Li W; Wu HL
    Chin J Integr Med; 2019 Feb; 25(2):96-102. PubMed ID: 30328569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac shock-wave therapy in the treatment of coronary artery disease: systematic review and meta-analysis.
    Burneikaitė G; Shkolnik E; Čelutkienė J; Zuozienė G; Butkuvienė I; Petrauskienė B; Šerpytis P; Laucevičius A; Lerman A
    Cardiovasc Ultrasound; 2017 Apr; 15(1):11. PubMed ID: 28403861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of cardiac shock wave therapy for patients with severe coronary artery disease: A randomized, double-blind control study.
    Jia N; Zhang R; Liu B; Liu B; Qi X; Lan M; Liu J; Zeng P; Chen C; Li W; Guo Y; Yao Z; He Q
    J Nucl Cardiol; 2022 Oct; 29(5):2404-2419. PubMed ID: 34476776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting the Benefits of Percutaneous Coronary Intervention on 1-Year Angina and Quality of Life in Stable Ischemic Heart Disease: Risk Models From the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation).
    Zhang Z; Jones P; Weintraub WS; Mancini GBJ; Sedlis S; Maron DJ; Teo K; Hartigan P; Kostuk W; Berman D; Boden WE; Spertus JA
    Circ Cardiovasc Qual Outcomes; 2018 May; 11(5):e003971. PubMed ID: 29752388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Effect of Cardiac Shock Wave Therapy on Myocardial Ischemia in Patients With Ischemic Heart Failure.
    Wang W; Liu H; Song M; Fang W; Yuan F
    J Cardiovasc Pharmacol Ther; 2016 Jul; 21(4):381-7. PubMed ID: 26657563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Extracorporeal cardiac shock wave therapy for treatment of coronary artery disease].
    Wang Y; Guo T; Cai HY; Ma TK; Tao SM; Chen MQ; Gu Y; Pan JH; Xiao JM; Zhao L; Yang XY; Yang C
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Aug; 38(8):711-5. PubMed ID: 21055138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Outcomes of Cardiac Shockwave Therapy in Severe Coronary Artery Disease Patients after Coronary Artery Bypass Grafting.
    Wang J; Jia N; Liu B; Zhang R; Liu B; Lan M; Liu J; Yao Z; He Q
    Int Heart J; 2023 Mar; 64(2):137-144. PubMed ID: 36927932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of catestatin and endocan with the effects of cardiac shock wave therapy: Biomarker sub-study of the randomized, sham procedure-controlled trial.
    Burneikaitė G; Shkolnik E; Puronaitė R; Zuozienė G; Petrauskienė B; Misonis N; Kazėnaitė E; Laucevičius A; Smih F; Rouet P; Čelutkienė J
    Front Cardiovasc Med; 2023; 10():1004574. PubMed ID: 36910537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac shock wave therapy for chronic refractory angina pectoris. A prospective placebo-controlled randomized trial.
    Schmid JP; Capoferri M; Wahl A; Eshtehardi P; Hess OM
    Cardiovasc Ther; 2013 Jun; 31(3):e1-6. PubMed ID: 22953794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac shock wave therapy reduces angina and improves myocardial function in patients with refractory coronary artery disease.
    Wang Y; Guo T; Cai HY; Ma TK; Tao SM; Sun S; Chen MQ; Gu Y; Pang JH; Xiao JM; Yang XY; Yang C
    Clin Cardiol; 2010 Nov; 33(11):693-9. PubMed ID: 21089114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A blinded, randomized, placebo-controlled trial of percutaneous laser myocardial revascularization to improve angina symptoms in patients with severe coronary disease.
    Leon MB; Kornowski R; Downey WE; Weisz G; Baim DS; Bonow RO; Hendel RC; Cohen DJ; Gervino E; Laham R; Lembo NJ; Moses JW; Kuntz RE
    J Am Coll Cardiol; 2005 Nov; 46(10):1812-9. PubMed ID: 16286164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness and safety of percutaneous myocardial laser revascularization for refractory angina pectoris.
    Salem M; Rotevatn S; Stavnes S; Brekke M; Vollset SE; Nordrehaug JE
    Am J Cardiol; 2004 May; 93(9):1086-91. PubMed ID: 15110197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.